Related Experiment Videos
Primary pelvic non-Hodgkin's lymphoma.
1Department of Obstetrics and Gynecology and Division of Gynecologic Oncology, St. Luke's-Roosevelt Hospital, New York, New York 10019, USA.
Obstetrics and Gynecology
|May 8, 2001
Summary
Primary pelvic non-Hodgkin's lymphoma is a rare gynecologic cancer. Early diagnosis and treatment lead to favorable outcomes, with most patients remaining disease-free post-therapy.
Area of Science:
- Gynecologic Oncology
- Hematology
- Oncology
Background:
- Primary pelvic non-Hodgkin's lymphoma (NHL) is a rare malignancy.
- This condition can mimic common gynecologic cancers, complicating diagnosis.
Observation:
- A 10-month period identified five cases of primary pelvic NHL.
- Tumors were located in the parasacral, uterine, vaginal, and ovarian regions.
- Presenting symptoms included pelvic pain, mass, and abnormal vaginal bleeding.
Findings:
- Histologic classification followed the Working Formulation, and staging used the Ann Arbor system.
- Treatment involved combination chemotherapy, with or without radiation therapy.
- Four out of five patients achieved disease-free survival at 20–33 months post-treatment.
Implications:
- Primary pelvic NHL should be included in the differential diagnosis for gynecologic malignancies.
- Timely diagnosis and appropriate treatment are crucial for patient outcomes.
- Further research into this rare condition is warranted.